BiotechTube
Home/Kamada/Joshua Berkman
JB

Joshua Berkman

Senior VP, Corporate Communications & Investor Relations

Kamada

Therapeutic Areas

Rare DiseasesPulmonologyImmunologyTransplant Medicine

Kamada Pipeline

DrugIndicationPhase
Inhaled AAT (KMA-001)Alpha-1 Antitrypsin Deficiency (AATD) with emphysemaPhase 3
IV AATGraft-Versus-Host Disease (GvHD)Phase 2
Anti-Rabies IgG (KamRab)Rabies Post-Exposure ProphylaxisMarketed

Leadership Team at Kamada

AL
Amir London
Chief Executive Officer
GN
Guy Neev
Chief Financial Officer
NG
Nathalie Gordin
Senior VP, Global Human Resources
DE
Dr. Eran Schenker
Chief Medical Officer
ER
Eran Reshef
Senior VP, Global Operations
RK
Roni Klapholz
Senior VP, Global Commercial Operations
View full Kamada profile